Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany
· Delayed Price · Currency is EUR 0.0010
-0.0024 (-70.59%)
At close: Dec 5, 2025
FRA:9RP Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 16.6 | 11.78 | 31.93 | 9.64 | 28.47 | 12.55 | Upgrade
|
| Cash & Short-Term Investments | 16.6 | 11.78 | 31.93 | 9.64 | 28.47 | 12.55 | Upgrade
|
| Cash Growth | 54.59% | -63.12% | 231.30% | -66.15% | 126.81% | 403.45% | Upgrade
|
| Accounts Receivable | - | 1.09 | - | - | 0.1 | 0.76 | Upgrade
|
| Other Receivables | 0.74 | 0.96 | 1.25 | 0.97 | 0.49 | 0.27 | Upgrade
|
| Receivables | 0.74 | 2.05 | 1.25 | 0.97 | 0.59 | 1.03 | Upgrade
|
| Prepaid Expenses | 0.47 | 0.77 | 0.38 | 0.09 | 0.11 | 0.07 | Upgrade
|
| Other Current Assets | - | 0 | - | 0.05 | 0.17 | 1.59 | Upgrade
|
| Total Current Assets | 17.81 | 14.6 | 33.55 | 10.74 | 29.33 | 15.24 | Upgrade
|
| Property, Plant & Equipment | 0.27 | 0.23 | 0.05 | 0.07 | 0.1 | - | Upgrade
|
| Total Assets | 18.08 | 14.82 | 33.6 | 10.82 | 29.43 | 15.24 | Upgrade
|
| Accounts Payable | 1.16 | 4.77 | 2.43 | 3.49 | 5.29 | 1.11 | Upgrade
|
| Accrued Expenses | 0.97 | 2.05 | 1.77 | 3.35 | 1.07 | 1 | Upgrade
|
| Other Current Liabilities | 0.87 | 0.24 | 0.96 | 0.11 | 0.11 | 0.15 | Upgrade
|
| Total Current Liabilities | 2.99 | 7.06 | 5.16 | 6.95 | 6.47 | 2.26 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | -0 | - | - | - | Upgrade
|
| Total Liabilities | 2.99 | 7.06 | 5.16 | 6.95 | 6.47 | 2.26 | Upgrade
|
| Common Stock | 2.4 | 0.59 | 14.25 | 2.28 | 1.1 | 0.53 | Upgrade
|
| Additional Paid-In Capital | 162.31 | 131.59 | 127.55 | 102.82 | 85.39 | 34.86 | Upgrade
|
| Retained Earnings | -149.61 | -124.41 | -113.36 | -101.23 | -63.52 | -22.41 | Upgrade
|
| Comprehensive Income & Other | -0 | -0 | 0 | - | - | - | Upgrade
|
| Shareholders' Equity | 15.09 | 7.76 | 28.45 | 3.87 | 22.96 | 12.98 | Upgrade
|
| Total Liabilities & Equity | 18.08 | 14.82 | 33.6 | 10.82 | 29.43 | 15.24 | Upgrade
|
| Net Cash (Debt) | 16.6 | 11.78 | 31.93 | 9.64 | 28.47 | 12.55 | Upgrade
|
| Net Cash Growth | 54.59% | -63.12% | 231.30% | -66.15% | 126.81% | 403.45% | Upgrade
|
| Net Cash Per Share | - | 0.09 | 0.50 | 0.66 | 3.16 | 2.84 | Upgrade
|
| Filing Date Shares Outstanding | - | 148.33 | 126.42 | 20.24 | 9.73 | 4.73 | Upgrade
|
| Total Common Shares Outstanding | - | 148.33 | 126.42 | 20.24 | 9.73 | 4.73 | Upgrade
|
| Working Capital | 14.82 | 7.54 | 28.4 | 3.8 | 22.87 | 12.98 | Upgrade
|
| Book Value Per Share | - | 0.05 | 0.22 | 0.19 | 2.36 | 2.74 | Upgrade
|
| Tangible Book Value | 15.09 | 7.76 | 28.45 | 3.87 | 22.96 | 12.98 | Upgrade
|
| Tangible Book Value Per Share | - | 0.05 | 0.22 | 0.19 | 2.36 | 2.74 | Upgrade
|
| Machinery | - | 0.36 | 0.12 | 0.12 | 0.12 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.